Incyte Corp (INCY)

Add to Watchlists
Create an Alert
63.60 +1.57  +2.53% NASDAQ Oct 16, 10:05 Delayed 2m USD

Incyte Corp Cash from Financing (TTM):

665.84M for June 30, 2018
View 4,000+ financial data types
Browse...
View Full Chart

Incyte Corp Cash from Financing (TTM) Chart

Export Data
Save Image
Print Image

Incyte Corp Historical Cash from Financing (TTM) Data

View and export this data going back to 1993. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2018 665.84M
March 31, 2018 670.81M
Dec. 31, 2017 690.17M
Sept. 30, 2017 700.32M
June 30, 2017 53.49M
March 31, 2017 70.72M
Dec. 31, 2016 58.64M
Sept. 30, 2016 52.06M
June 30, 2016 58.54M
March 31, 2016 61.94M
Dec. 31, 2015 84.74M
Sept. 30, 2015 106.56M
June 30, 2015 99.59M
March 31, 2015 81.21M
Dec. 31, 2014 93.06M
Sept. 30, 2014 294.89M
June 30, 2014 315.12M
March 31, 2014 302.35M
Dec. 31, 2013 275.59M
Sept. 30, 2013 52.14M
June 30, 2013 34.18M
March 31, 2013 52.07M
Dec. 31, 2012 47.71M
Sept. 30, 2012 41.98M
June 30, 2012 34.14M
   
March 31, 2012 28.76M
Dec. 31, 2011 19.47M
Sept. 30, 2011 21.26M
June 30, 2011 23.57M
March 31, 2011 13.49M
Dec. 31, 2010 -145.05M
Sept. 30, 2010 -188.27M
June 30, 2010 89.38M
March 31, 2010 87.84M
Dec. 31, 2009 242.25M
Sept. 30, 2009 282.46M
June 30, 2009 103.69M
March 31, 2009 104.36M
Dec. 31, 2008 104.88M
Sept. 30, 2008 115.66M
June 30, 2008 13.47M
March 31, 2008 12.75M
Dec. 31, 2007 12.32M
Sept. 30, 2007 -90.17M
June 30, 2007 21.68M
March 31, 2007 21.56M
Dec. 31, 2006 31.70M
Sept. 30, 2006 123.42M
June 30, 2006 4.189M
March 31, 2006 -24.16M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Financing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
Learn More

Advertisement

INCY Cash from Financing (TTM) Benchmarks

Benchmarks
Regeneron Pharmaceuticals Inc -216.51M
Vertex Pharmaceuticals Inc 253.68M
Gilead Sciences Inc -2.23B

INCY Cash from Financing (TTM) Range, Past 5 Years

Minimum 52.06M Sep 2016
Maximum 700.32M Sep 2017
Average 249.24M

INCY Cash from Financing (TTM) Excel Add-In Codes

  • Metric Code: cash_financing_ttm
  • Latest data point: =YCP("INCY", "cash_financing_ttm")
  • Last 5 data points: =YCS("INCY", "cash_financing_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.